Hangzhou Tigermed Consulting Co Ltd represents values of trust, innovation, and excellence in the field of clinical research and drug development. As a leading contract research organization, Tigermed is committed to providing high-quality services and solutions to pharmaceutical companies globally. With a strong focus on integrity and professionalism, the company aims to assist clients in achieving their clinical development goals efficiently. Moreover, Tigermed values collaboration, aiming to foster meaningful partnerships with its clients and professionals in the healthcare industry. Through cutting-edge technology and a customer-centric approach, Hangzhou Tigermed Consulting Co Ltd strives to be a reliable and strategic partner in advancing healthcare outcomes.

Hangzhou Tigermed Consulting Co Ltd is primarily present in China, as it is a Chinese company. However, it also has a significant presence in other countries and regions. With its global expansion strategy, Hangzhou Tigermed Consulting Co Ltd has established branches and offices in numerous locations worldwide. These include the United States, Japan, South Korea, Europe, Australia, and Southeast Asia. This widespread presence allows Hangzhou Tigermed Consulting Co Ltd to offer its comprehensive range of pharmaceutical and clinical research services to clients internationally.

Hangzhou Tigermed Consulting Co Ltd has achieved significant milestones in its history. As a leading contract research organization (CRO), the company has successfully established a global presence and expanded its service offerings. It has demonstrated its expertise in clinical research, regulatory affairs, and data management, serving clients across various therapeutic areas. Tigermed Consulting has also formed strategic partnerships with renowned pharmaceutical companies, positioning itself as a trusted partner in drug development and clinical trials. With its commitment to innovation and quality, Hangzhou Tigermed Consulting Co Ltd continues to make substantial advancements in the field of healthcare and contribute to improved patient outcomes.

Hangzhou Tigermed Consulting Co Ltd is a leading contract research organization (CRO) based in China. Founded in 2004, the company has rapidly grown to become one of the largest independent CROs in the country. Tigermed specializes in providing comprehensive clinical research and development services to pharmaceutical and biotech companies globally. With a strong focus on clinical trial management, regulatory affairs, and data management, Tigermed has established a solid reputation for delivering high-quality solutions to its clients. The company's commitment to excellence and extensive experience in the industry has enabled it to forge strong partnerships and contribute significantly to the advancement of healthcare research.

Some of the main competitors of Hangzhou Tigermed Consulting Co Ltd in the market include PPD Inc., ICON plc, QuintilesIMS, PAREXEL International Corporation, and Wuxi AppTec.

Hangzhou Tigermed Consulting Co Ltd is primarily active in the pharmaceutical and biotech industries.

The business model of Hangzhou Tigermed Consulting Co Ltd revolves around providing comprehensive and integrated clinical research services to support the development and marketing of pharmaceutical, biotechnological, and medical device products. As a leading Contract Research Organization (CRO) in China, Tigermed offers a wide range of services including project planning, clinical trial management, regulatory affairs, data management, statistical analysis, and quality assurance. By leveraging their expertise, experience, and strategic partnerships, Hangzhou Tigermed Consulting Co Ltd caters to the growing needs of domestic and international clients in the healthcare industry.

مُعامل القيمة السوقية إلى الأرباح لـ Hangzhou Tigermed Consulting Co هو ٣٠٫٦٨.

مُعامِل القيمة إلى المبيعات Hangzhou Tigermed Consulting Co هو ٥٫٠٥.

نقاط جودة AlleAktien لـ Hangzhou Tigermed Consulting Co هي 8/10.

المتوقعة Hangzhou Tigermed Consulting Co الإيرادات هي ٨٫٣٥ مليارات CNY.

صافي الربح المتوقعة Hangzhou Tigermed Consulting Co هو ١٫٣٧ مليارات CNY.

The Hangzhou Tigermed Consulting Co Ltd is a leading company in the field of clinical research, offering a wide range of services to its customers. The company was founded in 2004 and has its headquarters in Hangzhou, China. With offices in various cities in China, Europe, and the USA, the company now has over 800 employees worldwide. The business model of Tigermed Consulting is to support companies in developing and bringing new products to market. To this end, the company offers a wide range of services that span the entire product lifecycle. The company provides customers with support in the planning, execution, and evaluation of clinical studies, following applicable regulations and guidelines. The company specializes in clinical studies, regulatory affairs, medical devices, biostatistics, and medical writing services. Tigermed Consulting offers unique services to its customers, providing comprehensive solutions for their clinical studies, regulatory matters, and medical products. The company has experienced significant growth in recent years by offering a broad range of customizable services tailored to the specific needs of its customers. Overall, the business model of Tigermed Consulting aims to help its customers stay competitive and successfully bring their products to market. In a world driven by new technologies and innovations, it is important to leverage the expertise of companies like Tigermed Consulting to operate a successful and profitable business.

يوزع Hangzhou Tigermed Consulting Co أرباحًا قدرها ٠٫٥٠ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Hangzhou Tigermed Consulting Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـHangzhou Tigermed Consulting Co هو CNE100001KV8.

الرمز المُختصر لـ Hangzhou Tigermed Consulting Co هو 300347.SZ.

خلال آخر 12 شهراً، دفعت Hangzhou Tigermed Consulting Co توزيعات أرباح بقيمة ٠٫٥٥ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ١٫١٣ %. ومن المتوقع أن تدفع Hangzhou Tigermed Consulting Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٦٠ CNY.

نسبة توزيعات الأرباح الحالية لـ Hangzhou Tigermed Consulting Co هي ١٫١٣ %.

Hangzhou Tigermed Consulting Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يوليو, يونيو, أغسطس, أغسطس.

Hangzhou Tigermed Consulting Co دفعت توزيعات الأرباح كل عام خلال الـ14 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٦٠ CNY. وهذا يعادل عائد توزيعات أرباح قدره ١٫٢٢ %.

Hangzhou Tigermed Consulting Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٥٦٨ CNY من Hangzhou Tigermed Consulting Co المُعلن عنها في ١٢‏/٧‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٢‏/٧‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٢‏/٧‏/٢٠٢٤.

في العام 2023، وزعت Hangzhou Tigermed Consulting Co ٠٫٥ CNY كأرباح أسهم.

يتم توزيع أرباح Hangzhou Tigermed Consulting Co بالعملة CNY.